Template:Infobox drug/testcases11

• Merge Template:Infobox neurohormone(edit talk links history) into Template:Infobox drug(edit talk links history) (2017)
• Add gene therapy section (2018)

This testcase page uses {{Infobox drug/sandbox}}. Diff: compare (pages: Template:Infobox drug, Template:Infobox drug/sandbox).

• Testing Gene therapy

Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM

/sandbox: {{Drugbox}} · {{title}} ·  · src {{licence}} ·  · src {{legal}} ·  · src {{pregcat}} ·  · src {{molarmass}} ·  · src {{mab source}} ·  · src {{localINNvar}} ·  · src {{maint cat}} ·  · src {{fmtATC}} ·  · src /format · Infobox drug/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit) FDA-2023 {{Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023  · /sandbox2 parameters Full parameter list () · Type-conditional sections TPU cats:Category:Infobox drug tracking categories (32): Category:Pages using infobox drug with unknown parameters (12) · Parameter usage report cat:IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{cascite}} chembox {{Chem/dev/nav}} · {{Chembox}} Infobox drug class/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit)

• Diff: compare (pages: Template:Infobox drug, Template:Infobox drug/sandbox).

Has (data page)

Template:Infobox drug/testcases11 (data page)

This page has a data page to test this situation. (example: Caffeine has Caffeine (data page))

(data page)

Jan 2022: |data page=

This testpage has DP: Template:Infobox drug/testcases11 (data page)

(new) {{Infobox drug/data page link}}

• |data page= absent (dflt)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dflt Data page Template:Infobox drug/testcases11 (data page)	Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dflt Data page Template:Infobox drug/testcases11 (data page)

• |data page=<blank>

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=blank Data page Template:Infobox drug/testcases11 (data page)	Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=blank Data page Template:Infobox drug/testcases11 (data page)

|data page=Water (data page)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=water(DP) Data page Water (data page)	Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=water(DP) Data page Water (data page)

|data page=[[Water (data page)]]

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=[water(DP)] Data page Water (data page)	Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=[water(DP)] Data page Water (data page)

|data page=none

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=none	Infobox drug/testcases11 Clinical data Pronunciation test (DP) -dp=none

other older

|data page=Water (data page)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Data page Template:Infobox drug/testcases11 (data page)  NY (what is this?)  (verify)	Infobox drug/testcases11 Data page Template:Infobox drug/testcases11 (data page)  NY (what is this?)  (verify)

|dat_ page=Foobar (xyz page)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Data page Template:Infobox drug/testcases11 (data page)  NY (what is this?)  (verify)	Infobox drug/testcases11 Data page Template:Infobox drug/testcases11 (data page)  NY (what is this?)  (verify)

Gene therapy

• Pilot article is Voretigene neparvovec

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Gene therapy Target gene RPE65 Vector adenovirus serotype 2 Nucleic acid type [not applicable here] Editing method [not applicable here] Delivery method [not applicable here] Data page Template:Infobox drug/testcases11 (data page)	Infobox drug/testcases11 Gene therapy Target gene RPE65 Vector adenovirus serotype 2 Nucleic acid type [not applicable here] Editing method [not applicable here] Delivery method [not applicable here] Data page Template:Infobox drug/testcases11 (data page)

2

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases11 Gene therapy Target gene RPE65 Vector adenovirus serotype 2 Nucleic acid type [not applicable here] Editing method [not applicable here] Delivery method [not applicable here] Data page Template:Infobox drug/testcases11 (data page)	Infobox drug/testcases11 Gene therapy Target gene RPE65 Vector adenovirus serotype 2 Nucleic acid type [not applicable here] Editing method [not applicable here] Delivery method [not applicable here] Data page Template:Infobox drug/testcases11 (data page)

Testcase 1

Testcase comparing the previous template (now deprecated)

nowiki

{| style="vertical-align:top" |- | colspan=2 | [[Oxytocin]] |- | {{tl|Infobox drug/sandbox}} | {{tl|Infobox neurohormone}} |- |{{Infobox drug/sandbox | type= | drug_name = Oxytocin (hormone) | IUPAC_name = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-<small>L</small>-prolyl-<small>L</small>-leucylglycinamide | image = Oxytocin with labels.png | width = 250px <!-- Physiology --> | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]] | legal_US= blabla-test | class = clinicalclass <!--Pharmacokinetic data--> | bioavailability = | protein_bound = 30% <!--Identifiers--> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} |{{Infobox neurohormone <!-- Nomenclature and image --> | name = Oxytocin (hormone) | alt = <!--alt text for screenreaders--> | IUPACName = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-<small>L</small>-prolyl-<small>L</small>-leucylglycinamide | synonyms = | abbrev = <!--abbreviated name--> | image = Oxytocin with labels.png <!-- Neuropharmacology --> | sources = [[posterior pituitary]] | targets = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | synth = [[magnolysin]] | breakdown = [[oxytocinase]] <!-- Database links --> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N | footnotes = }} |}

test metabolism in two sections

{{Infobox drug/sandbox}}

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

M. with physiological data only Physiological data Source tissues posterior pituitary Target tissues central nervous system Receptors oxytocin receptor Agonists carbetocin, demoxytocin, merotocin Antagonists atosiban, epelsiban, retosiban Precursor oxytocin-neurophysin 1 Biosynthesis magnolysin Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

M. with physiological data only Physiological data Source tissues posterior pituitary Target tissues central nervous system Receptors oxytocin receptor Agonists carbetocin, demoxytocin, merotocin Antagonists atosiban, epelsiban, retosiban Precursor oxytocin-neurophysin 1 Biosynthesis magnolysin Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

M. with pharmacokinetic data only Pharmacokinetic data Bioavailability xyz Protein binding 30% Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

M. with pharmacokinetic data only Pharmacokinetic data Bioavailability xyz Protein binding 30% Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

M. with physio and pharmacokin data both Physiological data Source tissues posterior pituitary Target tissues central nervous system Receptors oxytocin receptor Agonists carbetocin, demoxytocin, merotocin Antagonists atosiban, epelsiban, retosiban Precursor oxytocin-neurophysin 1 Biosynthesis magnolysin Metabolism oxytocinase Pharmacokinetic data Bioavailability xyz Protein binding 30% Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

M. with physio and pharmacokin data both Physiological data Source tissues posterior pituitary Target tissues central nervous system Receptors oxytocin receptor Agonists carbetocin, demoxytocin, merotocin Antagonists atosiban, epelsiban, retosiban Precursor oxytocin-neurophysin 1 Biosynthesis magnolysin Metabolism oxytocinase Pharmacokinetic data Bioavailability xyz Protein binding 30% Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N Y Data page Template:Infobox drug/testcases11 (data page)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
M. with M. value only Pharmacokinetic data Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 Data page Template:Infobox drug/testcases11 (data page)	M. with M. value only Pharmacokinetic data Metabolism oxytocinase Identifiers CAS Number 50-56-6 Y Chemical and physical data Formula C43H66N12O12S2 Molar mass 1007.19 g/mol g·mol−1 Data page Template:Infobox drug/testcases11 (data page)

text metabolism, and pronunciation

nowiki

{{tl|Infobox drug/sandbox}} {{testcase table | type= | drug_name = M. with physiological data only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg <!-- Physiology --> | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]] <!--Pharmacokinetic data--> | bioavailability = | protein_bound = <!-- 30% --> <!--Identifiers--> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with pharmacokinetic data only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg <!-- Physiology --> | metabolism = [[oxytocinase]] <!--Pharmacokinetic data--> | bioavailability = xyz | protein_bound = 30% <!--Identifiers--> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with physio and pharmacokin data both | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg <!-- Physiology --> | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]] <!--Pharmacokinetic data--> | bioavailability = xyz | protein_bound = 30% <!--Identifiers--> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with M. value only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg <!-- Physiology --> | source_tissues = | target_tissues = | receptors = | agonists = | antagonists = | precursor = | biosynthesis = | metabolism = [[oxytocinase]] <!--Pharmacokinetic data--> | bioavailability = | protein_bound = <!--Identifiers--> | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6 <!--Chemical data--> | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol }}